December 23, 2021

Harbour Antibodies BV et al v. Teneobio, Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 07, 2022

    Special Master Says DLA Piper Can Rep Co. Suing Amgen Unit

    A special master in Delaware has recommended clearing DLA Piper to represent a Dutch developer of biomedical mice in the company's patent lawsuit against a rival recently purchased by Amgen, despite the BigLaw firm's ongoing work handling "environmental, social, and governance initiatives" for Amgen. 


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!